Physician profile
Megan E Bartlett
NPI 1407125065
$2,437.88
in general payments reported to CMS, 2019-2025
19 companies · $87.15 in 2025
The $87.15 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $883 · 2022: $639 · 2023: $481 · 2024: $348 · 2025: $87.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.81 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $974.04 | 2021-2025 | |
| Janssen Biotech, INC. | $375.09 | 2021-2024 | Tremfya |
| Novartis Pharmaceuticals Corporation | $261.98 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $129.33 | 2023-2024 | Sotyktu |
| Dermavant Sciences, INC. | $108.64 | 2023-2024 | Vtama |
| Pfizer INC. | $95.20 | 2021-2024 | |
| Ucb, INC. | $89.78 | 2021-2024 | Bimzelx |
| Stemline Therapeutics INC. | $76.50 | 2021 | |
| Lilly USA, LLC | $65.47 | 2021-2023 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $41.66 | 2021 | |
| Genentech USA, INC. | $36.57 | 2021-2022 | |
| Csl Behring | $34.98 | 2025 | Andembry |
| Takeda Pharmaceuticals U.S.A., INC. | $31.13 | 2024 | Fruzaqla |
| Galderma Laboratories, L.P. | $29.62 | 2023 | Aklief, Epsolay |
| Fresenius Kabi USA, LLC | $21.32 | 2023 | Idacio |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $18.71 | 2025 | Zoryve |
| Amgen INC. | $17.33 | 2023 | Otezla |
| Astrazeneca Pharmaceuticals LP | $16.85 | 2025 | Airsupra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.